Inhaltsbereich
| 83 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
 Druckansicht
|
| Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo. |
| Pinter M, Ulbrich G, Sieghart W, Kölblinger C, Reiberger T, Li S, Ferlitsch A, Müller C, Lammer J, Peck-Radosavljevic M |
| Radiology. 2015 Jul 1. doi: 10.1148/radiol.2015142140 |
| PMID: 26131911 |
| Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice. |
| Kortüm B, Campregher C, Lang M, Khare V, Pinter M, Evstatiev R, Schmid G, Mittlböck M, Scharl T, Kucherlapati MH, Edelmann W, Gasche C |
| Gut. 2014 Nov 26. pii: gutjnl-2014-307663. doi: 10.1136/gutjnl-2014-307663 |
| PMID: 25429050 |
| Epidemiological trends of hepatocellular carcinoma in Austria. |
| Pinter M, Hucke F, Zielonke N, Trauner M, Sieghart W, Peck-Radosavljevic M |
| Digestive diseases (Basel, Switzerland). 2014 Oct 29. pii: 000367983. doi: 10.1159/000367983 |
| PMID: 25376282 |
| How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma. |
| Hucke F, Pinter M, Graziadei I, Bota S, Vogel W, Müller C, Heinzl H, Waneck F, Trauner M, Peck-Radosavljevic M, Sieghart W |
| Journal of hepatology. 2014 Jul 10. pii: S0168-8278(14)00470-X. doi: 10.1016/j.jhep.2014.07.002 |
| PMID: 25016222 |
| Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma. |
| Pinter M, Sieghart W, Schmid M, Dauser B, Prager G, Dienes HP, Trauner M, Peck-Radosavljevic M |
| United European gastroenterology journal. 2014 Jun 11. doi: 10.1177/2050640613496605. pii: 10.1177_2050640613496605. pmc: PMC4040790 |
| PMID: 24917971 |
| Incidence and mortality trends for biliary tract cancers in Austria. |
| Pinter M, Hucke F, Zielonke N, Waldhör T, Trauner M, Peck-Radosavljevic M, Sieghart W |
| Liver international : official journal of the International Association for the Study of the Liver. 2013 Oct 2. doi: 10.1111/liv.12325 |
| PMID: 24119058 |
| The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE. |
| Hucke F, Sieghart W, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Waneck F, Trauner M, Peck-Radosavljevic M |
| Journal of hepatology. 2013 Sep 3. pii: S0168-8278(13)00617-X. doi: 10.1016/j.jhep.2013.08.022 |
| PMID: 24012941 |
| The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. |
| Sieghart W, Hucke F, Pinter M, Graziadei I, Vogel W, Müller C, Heinzl H, Trauner M, Peck-Radosavljevic M |
| Hepatology (Baltimore, Md.). 2013 May 3. doi: 10.1002/hep.26256 |
| PMID: 23316013 |
| Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma. |
| Sieghart W, Pinter M, Hucke F, Graziadei I, Schöniger-Hekele M, Müller C, Vogel W, Trauner M, Peck-Radosavljevic M |
| Hepatology (Baltimore, Md.). 2013 Jan 18. doi: 10.1002/hep.26057 |
| PMID: 22961713 |
| Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. |
| Sieghart W, Pinter M, Dauser B, Rohr-Udilova N, Piguet AC, Prager G, Hayden H, Dienes HP, Dufour JF, Peck-Radosavljevic M |
| Journal of hepatology. 2012 May 24. pii: S0168-8278(12)00364-9. doi: 10.1016/j.jhep.2012.04.034 |
| PMID: 22634341 |
| Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study. |
| Sieghart W, Pinter M, Reisegger M, Müller C, Ba-Ssalamah A, Lammer J, Peck-Radosavljevic M |
| European radiology. 2012 Jan 4. doi: 10.1007/s00330-011-2368-z |
| PMID: 22215073 |
| Sorafenib in unresectable intrahepatic cholangiocellular carcinoma: a case report. |
| Pinter M, Sieghart W, Reisegger M, Wrba F, Peck-Radosavljevic M |
| Wiener klinische Wochenschrift. 2011 Jan 19. doi: 10.1007/s00508-010-1522-y |
| PMID: 21240686 |
| Subcutaneous target stimulation (STS) in chronic noncancer pain: a nationwide retrospective study. |
| Sator-Katzenschlager S, Fiala K, Kress HG, Kofler A, Neuhold J, Kloimstein H, Ilias W, Mozes-Balla EM, Pinter M, Loining N, Fuchs W, Heinze G, Likar R |
| Pain practice : the official journal of World Institute of Pain. 2010 Mar 3. pii: PPR351. doi: 10.1111/j.1533-2500.2009.00351.x |
| PMID: 20230450 |
| Cancer and liver cirrhosis: implications on prognosis and management. |
| Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W |
| ESMO open. doi: 10.1136/esmoopen-2016-000042. pii: esmoopen-2016-000042 |
| PMID: 27843598 |
| The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab. |
| Li S, Peck-Radosavljevic M, Ubl P, Wadsak W, Mitterhauser M, Rainer E, Pinter M, Wang H, Nanoff C, Kaczirek K, Haug A, Hacker M |
| European journal of nuclear medicine and molecular imaging. 2017 May 29. doi: 10.1007/s00259-017-3724-2. pii: 10.1007/s00259-017-3724-2 |
| PMID: 28555333 |
| Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib. |
| Rohr-Udilova N, Klinglmüller F, Seif M, Hayden H, Bilban M, Pinter M, Stolze K, Sieghart W, Peck-Radosavljevic M, Trauner M |
| Oncotarget. 2017 Jul 6. pii: 19055. doi: 10.18632/oncotarget.19055 |
| PMID: 28711906 |
| The impact of thyroid hormones on patients with hepatocellular carcinoma. |
| Pinter M, Haupt L, Hucke F, Bota S, Bucsics T, Trauner M, Peck-Radosavljevic M, Sieghart W |
| PloS one. 2017 Aug 3. doi: 10.1371/journal.pone.0181878. pii: PONE-D-17-11614 |
| PMID: 28771610 |
| Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib. |
| Rohr-Udilova N, Klinglmüller F, Seif M, Hayden H, Bilban M, Pinter M, Stolze K, Sieghart W, Peck-Radosavljevic M, Trauner M |
| Oncotarget. 2017 Jul 6. doi: 10.18632/oncotarget.19055. pii: 19055. pmc: PMC5593629 |
| PMID: 28915658 |
| Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. |
| Pinter M, Jain RK |
| Science translational medicine. 2017 Oct 5. pii: 9/410/eaan5616. doi: 10.1126/scitranslmed.aan5616 |
| PMID: 28978752 |
| Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma. |
| Pinter M, Weinmann A, Wörns MA, Hucke F, Bota S, Marquardt JU, Duda DG, Jain RK, Galle PR, Trauner M, Peck-Radosavljevic M, Sieghart W |
| United European gastroenterology journal. 2017 Feb 26. doi: 10.1177/2050640617695698. pii: 10.1177_2050640617695698. pmc: PMC5676550 |
| PMID: 29163965 |
| 83 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
